iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 8.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,901 shares of the financial services provider’s stock after acquiring an additional 669 shares during the quarter. Signature Estate & Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,296,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of IBB. Blue Fin Capital Inc. increased its holdings in iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after buying an additional 74 shares during the last quarter. Security National Bank of SO Dak increased its holdings in iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares during the last quarter. SPC Financial Inc. increased its holdings in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its holdings in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC increased its holdings in iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after buying an additional 82 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 4.8 %

NASDAQ:IBB opened at $133.38 on Friday. The stock has a 50 day moving average of $144.49 and a 200-day moving average of $141.59. iShares Biotechnology ETF has a 52 week low of $116.70 and a 52 week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.